BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28199176)

  • 1. Handling Protest Responses in Contingent Valuation Surveys.
    Pennington M; Gomes M; Donaldson C
    Med Decis Making; 2017 Aug; 37(6):623-634. PubMed ID: 28199176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing protest responses in contingent valuation: A conceptualization of motivations and attitudes behind them.
    Frey UJ; Pirscher F
    PLoS One; 2019; 14(1):e0209872. PubMed ID: 30620731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating a WTP-based value of a QALY: the 'chained' approach.
    Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
    Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia.
    Shafie AA; Lim YW; Chua GN; Hassali MA
    Clinicoecon Outcomes Res; 2014; 6():473-81. PubMed ID: 25364267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating willingness to pay for public health insurance while accounting for protest responses: A further step towards universal health coverage in Tunisia?
    Abu-Zaineh M; Chanel O; Makhloufi K
    Int J Health Plann Manage; 2022 Sep; 37(5):2809-2821. PubMed ID: 35607299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing WTP values of different types of QALY gain elicited from the general public.
    Pennington M; Baker R; Brouwer W; Mason H; Hansen DG; Robinson A; Donaldson C;
    Health Econ; 2015 Mar; 24(3):280-93. PubMed ID: 25625510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Missing Values and Protest Zeros in Contingent Valuation in Dental Medicine.
    Sendi P; Ramadani A; Bornstein MM
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample restrictions and the elicitation of a constant willingness to pay per quality adjusted life year.
    Nielsen JS; Gyrd-Hansen D; Kjaer T
    Health Econ; 2021 May; 30(5):923-931. PubMed ID: 33569834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
    Mavrodi A; Aletras V
    Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accounting protesting and warm glow bidding in Contingent Valuation surveys considering the management of environmental goods--an empirical case study assessing the value of protecting a Natura 2000 wetland area in Greece.
    Grammatikopoulou I; Olsen SB
    J Environ Manage; 2013 Nov; 130():232-41. PubMed ID: 24091158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
    Olofsson S; Norrlid H; Persson U
    J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
    Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
    Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating a constant WTP for a QALY-a mission impossible?
    Sund B; Svensson M
    Eur J Health Econ; 2018 Jul; 19(6):871-880. PubMed ID: 28932914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project.
    Baker R; Bateman I; Donaldson C; Jones-Lee M; Lancsar E; Loomes G; Mason H; Odejar M; Pinto Prades JL; Robinson A; Ryan M; Shackley P; Smith R; Sugden R; Wildman J;
    Health Technol Assess; 2010 May; 14(27):1-162. PubMed ID: 20525460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to pay for one quality-adjusted life year in Iran.
    Moradi N; Rashidian A; Nosratnejad S; Olyaeemanesh A; Zanganeh M; Zarei L
    Cost Eff Resour Alloc; 2019; 17():4. PubMed ID: 30867654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of protest zeros on estimates of willingness to pay in healthcare contingent valuation analysis.
    Fonta WM; Ichoku HE; Kabubo-Mariara J
    Appl Health Econ Health Policy; 2010; 8(4):225-37. PubMed ID: 20578778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences.
    Martín-Fernández J; Polentinos-Castro E; del Cura-González MI; Ariza-Cardiel G; Abraira V; Gil-LaCruz AI; García-Pérez S
    BMC Health Serv Res; 2014 Jul; 14():287. PubMed ID: 24989615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec.
    Kouakou CRC; He J; Poder TG
    Eur J Health Econ; 2024 Jul; 25(5):787-811. PubMed ID: 37656261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of a QALY and VSI estimated with the chained approach.
    Olofsson S; Gerdtham UG; Hultkrantz L; Persson U
    Eur J Health Econ; 2019 Sep; 20(7):1063-1077. PubMed ID: 31172400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of willingness to pay techniques to consumers.
    Taylor SJ; Armour CL
    Health Expect; 2002 Dec; 5(4):341-56. PubMed ID: 12460223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.